Fundraising Fox株式会社Liquid Mine
Tokyo, JP · Founded 2019 · 2 known investors
Find your way into 株式会社Liquid Mine
Sign up to see every warm intro you have to 株式会社Liquid Mine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社Liquid Mine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Liquid Mine develops MyRD®, a liquid biopsy-based genomic testing system that creates personalized diagnostic tests for leukemia and other cancers by analyzing individual patient genetic mutations. The company aims to advance precision medicine in oncology by making genomic testing more accessible, particularly in Japan, through collaboration with Tokyo University's Institute of Medical Science.
Founders & leadership
岸倫
岸本 倫和代表取締役社長
Investors · 2
Frequently asked questions
- What does 株式会社Liquid Mine do?
- Liquid Mine develops MyRD®, a liquid biopsy-based genomic testing system that creates personalized diagnostic tests for leukemia and other cancers by analyzing individual patient genetic mutations. The company aims to advance precision medicine in oncology by making genomic testing more accessible, particularly in Japan, through collaboration with Tokyo University's Institute of Medical Science.
- Who are 株式会社Liquid Mine's investors?
- 株式会社Liquid Mine's investors include aSTART, Plug and Play Ventures.
- Where is 株式会社Liquid Mine headquartered?
- 株式会社Liquid Mine is headquartered in Tokyo, JP.